Dr. Farnaz Memarzadeh, MD

Dr. Memarzadeh practices at Fontana Medical Center in Fontana, California.

Dr. Memarzadeh's NPI, 1093934200, was assigned on April 25, 2007. Dr. Memarzadeh graduated from University of Pittsburgh School of Medicine in 2001. Dr. Memarzadeh holds California license A79896.

Dr. Memarzadeh's primary practice is Fontana Medical Center, at 9961 Sierra Ave, Fontana, CA 92335 in San Bernardino County. The practice phone is (909) 427-3910.

Dr. Memarzadeh's primary practice is Fontana Medical Center in Fontana, California. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Memarzadeh to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Memarzadeh practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Memarzadeh's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Memarzadeh is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Memarzadeh is licensed in California.

Dmand AI lists glaucoma and glaucoma surgery among the conditions Dr. Memarzadeh treats.

CMS data shows 16 Medicare services from Dr. Memarzadeh across 1 procedure code in 2024, all of them office visits, for 23 Medicare patients. Medicare paid $593 for them. Every service was in an office.

CMS counts 23 Medicare patients who saw Dr. Memarzadeh in 2024. The largest group is 65 to 74, with 12 patients. 65% of them have diabetes, and 52% have high blood pressure. 48% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Memarzadeh's median patient age at 72, with 55% women.

In 2024, Dr. Memarzadeh wrote 6,025 Medicare Part D claims for 1,054 patients. 79% of them were for generic drugs. CMS names the drug for 5,905 of them, across 24 drugs with 11 or more claims each, at $518,815 in total drug cost. In 2023, CMS named 5,391 claims across 23 drugs.

Dr. Memarzadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Memarzadeh in 2011. Dr. Memarzadeh's most frequent co-authors are Vikas Chopra, MD and Rohit Varma, MD.

CMS Open Payments shows 19 general payments to Dr. Memarzadeh from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Alcon Laboratories Inc paid the most, $236.

Dmand AI lists 1 award for Dr. Memarzadeh, most recently CMS Stage 1 2012 in 2011.

Dr. Memarzadeh graduated from University of Pittsburgh School of Medicine in 2001.

Dr. Memarzadeh is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.